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Dystonia is defined as a neurological syndrome characterized by involuntary sustained
or intermittent muscle contractions causing twisting, often repetitive movements, and
postures. Paroxysmal dyskinesias are episodic movement disorders encompassing dys-
tonia, chorea, athetosis, and ballism in conscious individuals. Several decades of research
have enhanced the understanding of the etiology of human dystonia and dyskinesias
that are associated with dystonia, but the pathophysiology remains largely unknown. The
spontaneous occurrence of hereditary dystonia and paroxysmal dyskinesia is well docu-
mented in rodents used as animal models in basic dystonia research. Several hyperkinetic
movement disorders, described in dogs, horses and cattle, show similarities to these
human movement disorders. Although dystonia is regarded as the third most common
movement disorder in humans, it is often misdiagnosed because of the heterogeneity of
etiology and clinical presentation. Since these conditions are poorly known in veterinary
practice, their prevalence may be underestimated in veterinary medicine. In order to
attract attention to these movement disorders, i.e., dystonia and paroxysmal dyskinesias
associated with dystonia, and to enhance interest in translational research, this review
gives a brief overview of the current literature regarding dystonia/paroxysmal dyskinesia
in humans and summarizes similar hereditary movement disorders reported in domestic
animals.
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INTRODUCTION
Dystonia is characterized by sustained or intermittent muscle contractions causing abnormal,
often repetitive, movements, postures, or both. Dystonic movements, which are typically pat-
terned, twisting and sometimes tremulous, can be initiated or worsened by voluntary action
(1). Dystonia is the third most common movement disorder in humans and comprises a large
number of types, currently classified by (1) clinical characteristics (age at onset, body distribution,
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TABLE 1 | Classification of dystonia (1).
(A) CLINICAL CHARACTERISTICS OF DYSTONIA
Age of onset (infancy, childhood, adolescence, and early/late adulthood)
Body distribution
Focal (only one body region is affected. e.g., blepharospasm)
Segmental (two or more contiguous body regions are affected)
Multifocal (two non-contiguous or more – contiguous or not – body regions are
involved)
Hemidystonia (more body regions restricted to one body side are involved)
Generalized (involvement of the trunk and at least two other sites, including leg or
not)
Temporal pattern
Course of disease (static or progressive)
Variability
Persistent (appears to approximately the same extent throughout the day)
Diurnal (recognizable circadian variations in occurrence, severity and
phenomenology)
Action-specific (occurs only during a particular activity or task)
Paroxysmal (sudden self-limited episodes of dystonia usually induced by a
trigger)
Associated features
Isolated dystonia (dystonia is the only sign, with the exception of tremor)
Combined with other movement disorders (e.g., myoclonus)
Associated with other neurological symptoms (e.g., cognitive decline) or systemic
manifestations (e.g., Wilson disease)
(B) ETIOLOGY
Nervous system pathology
Evidence of degeneration
Evidence of structural (often static) lesions
No evidence of degeneration or structural lesion
Inherited or acquired
Inherited (autosomal dominant, autosomal recessive, X-linked recessive, and
mitochondrial)
Acquired (brain injury, infection, drug, toxic, vascular, neoplastic, and psychogenic)
Idiopathic (sporadic and familial)
temporal pattern and associated features) and (2) etiology (ner-
vous system pathology, inherited or acquired), as summarized
in Table 1. Although the term dyskinesia includes a wide range
of abnormal, involuntary movements that can be associated with
many neurological disorders, it is currentlymainly used for parox-
ysmal dyskinesias (Table 2) and drug-induced dyskinesias in
human neurology (2, 3). Paroxysmal dyskinesias are characterized
by self-limiting episodes, usually induced by stress or sudden
movements (4). These episodic disorders include dystonia and
also other abnormal involuntary, non-stereotypical movements,
such as chorea (rapid, distal dance-like movements), athetosis
(slow writing movements), and ballism (rapid, more violent, pre-
dominantly involving proximal muscle groups). The term “hyper-
kinesia” includes these syndromes as well as any unwanted excess
movements (5). Dystonia can be the dominant feature in parox-
ysmal dyskinesias, termed “paroxysmal dystonia” in Table 1 (1).
Diagnosing dystonia has been described as difficult, because of
variability in clinical presentation, the wide etiological spectrum,
and possible coexistencewith othermovement disorders (6). It has
been estimated that about 3million people suffer from dystonia
worldwide (7, 8).
In laboratory animals, dystonic phenotypes caused by sponta-
neousmutations are well-known, as described in previous reviews
as animal models of dystonia (9–12). It is, therefore, unlikely
that this movement disorder is restricted to human patients. In
domestic animals, it is probably often unrecognized and becomes
a reason for euthanasia in severe and intractable cases. Several
case reports of “cramps” and “hyperkinesia” in veterinary jour-
nals as well as online videos suggest that dystonic clinical signs
deserve attention in veterinary practice. There is, however, little
research on how closely these features resemble human dystonia
or paroxysmal dyskinesias which are associated with dystonia.
Since diagnosis of potential cases in domestic animals is impor-
tant for prognosis, genetic counseling, and treatment of affected
individuals, this review provides a comparative view on these
movement disorders.
Academics of different expertise need to collaborate to under-
stand the underlying pathogenesis of the dystonic syndrome (13,
14). The aim of this review is to explore the possibility that
distinct neurological movement disorders in domestic animals,
rarely described in the literature, represent a type of dystonia or
dystonia-associated dyskinesia. As for laboratory animal models,
much also could be learned from domestic animals about the
pathogenesis of human dystonia (11). In the first part, we give a
brief overview of the knowledge of human dystonia/paroxysmal
dyskinesias and refer to several excellent reviews on this topic.
In the second part, we draw comparisons between movement
disorders in domestic animals and human dystonia/paroxysmal
dyskinesias.
CLINICAL AND NEUROPHYSIOLOGICAL
CHARACTERISTICS OF DYSTONIA AND
CLASSIFICATION
Not all involuntarymuscle contractions are dystonic in nature and
there is no neurophysiological proof or confirmation of dysto-
nia. However, there is a measurable neurophysiological defect in
motor control, with excitability changes of interneural circuitry
at spinal cord, brainstem (15, 16) and cortical level (17, 18), as
well as the preparatory phase before voluntary movements (19,
20), which is possibly due to disturbed basal-ganglia nuclei input
to these structures (21). A hallmark of dystonic contractions is
their consistent directionality (22). The dystonic movements are
patterned and repeatedly involve the same muscle groups within
individuals. During dystonic movements, agonist and antagonist
muscles typically contract simultaneously, thereby causing twist-
ing of body parts. Poly-electromyographical recordings (poly-
EMG: minimum of two channels) have shown three types of
muscular activity during rest or voluntary movements: (1) long
spasms, lasting several seconds, (2) repetitive rhythmical cocon-
tracting spasms (200–500ms), or (3) brief (<100ms) irregular
cocontracting jerks (23). Poly-EMG features of dystonia there-
fore match the clinical impression of cocontracting antagonis-
tic muscles, with mainly tonic, non-reciprocal patterns during
rest or voluntary movement (24–27). Dystonic movements often
are longer lasting (or more persistent) than in other disorders
such as myoclonus. Dystonia with myoclonic patterns are usu-
ally superimposed on long-lasting tonic activation (28). Dystonic
spasms or jerky/myoclonic movements in dystonia clinically look
similar to those of primary myoclonus but are not associated
with electroencephalographic (EEG) changes (15). Repetitive con-
tractions can cause jerking (tremulous) movements which might
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TABLE 2 | Types of paroxysmal dyskinesias (4).
Term Duration Frequency Trigger Response to antiepileptic drugs
Paroxysmal kinesigenic dyskinesia (PKD) Typically <2min Up to 100 per day Sudden movements Often effective
Paroxysmal non-kinesigenic dyskinesia
(PNKD)
5min to 4 h None for months to
few per day
Excitement, stress, fatigue,
alcohol, and caffeine
Usually not effective
Paroxysmal exertion induced dyskinesia (PED) 5–30min One per month to daily Prolonged muscle exertion Usually not effective
Paroxysmal hypnogenic dyskinesia (PHD);
type of frontal lobe epilepsy
30–45 s 5 times a year to five
times a night
During non-REM sleep Sometimes effective
Paroxysmal torticollis of infancy Hours to days Every 2 or 3weeks CHanges in posture Spontaneous disappearance before
the age of 5 years
mimic tremor though can be distinguished by their irregular
frequency. Dystonia is often worsened by voluntary movements
or, as in cases of action or task-specific dystonia, present during
voluntary movements and not during rest (e.g., writer’s cramp).
Motor actions can cause dystonic symptoms in other parts of
the body, called overflow phenomenon, for example writing can
initiate leg dystonia (1). Fatigue and stress often cause aggravation,
while the symptoms improve or disappear during relaxation and
sleep (22).
Classification of dystonia has been modified extensively over
the last few decades (1, 29). The current classification by clinical
characteristics is summarized in Table 1. Classification by the age
of onset is notable, because dystonia with first occurrence at an
early age ismore likely to progress from focal to generalized forms.
For diagnosis and therapy, the classification by the affected body
region and by the temporal pattern is important. Hemidystonia,
for example, is often acquired. Task-specific and paroxysmal types
have to be distinguished from pure action dystonia, where dys-
tonic features accompany any voluntary movement. In paroxys-
mal dyskinesia, the same trigger might not always induce symp-
toms and the attacks last longer than the influence of the trigger.
In contrast, action dystonia is predictably induced by the same
voluntarymotor activity and disappears when the inducing action
is stopped (1). Paroxysmal dyskinesias can present with dysto-
nia, choreic, ballistic, other, or a mixture of these hyperkinesias
and can be inherited or acquired (30). According to the trigger,
duration, frequency, and response to antiepileptic drugs, human
paroxysmal dyskinesias are divided into subtypes (see Table 2).
These paroxysmal dyskinesias often occur first in childhood or
early adolescence (4).
Differential Diagnoses
Twisting movements and postures can be caused by diverse dis-
orders of the central and peripheral nervous systems or by non-
neurological conditions. For example, tonic epileptic seizures can
produce torsions. Those epileptic seizures are usually accompa-
nied by a loss of consciousness, while dystonia (including parox-
ysmal types) occurs in awake individuals and in the absence
of EEG changes (spikes and waves). Episodic dystonic features
are not accompanied by autonomic signs and postictal behavior.
Furthermore, an exaggerated startle reflex to tactile and acoustic
stimuli, as known in hyperekplexia is not observed in dystonia.
Awareness is not disturbed in dystonic patients, and there are
no gross deficits in cognition (31). A hallmark of spasticity is
the pathology of reflexes, while hyperreflexia is not typical of
dystonia. However, moderate changes in spinal and brainstem
reflexes like a decreased inhibition in blink reflex recovery can
be present in patients with focal dystonia. Furthermore, tran-
scranial magnetic stimulation (TMS) studies revealed a loss of
inhibition of the primary motor cortex (32). Myoclonus differs
concerning duration and electrophysiological characteristics, as
described above. Infections and peripheral alterations have to be
excluded, such as trochlear nerve palsy or vestibulopathy which
can cause head tilt but not cervical dystonia. Sustained muscle
contraction may have neuromuscular causes (e.g., neuromyoto-
nia,myotonic disorders), and tetanic spasms can for example result
from hypocalcemia (22). Not all motor dysfunctions in animals
can be correlated to a specific human movement disorder. An
example of this would be the inherited hypertonicity syndrome
of Labrador Retrievers described by Vanhaesebrouck et al. (33),
which is associated with a selective loss of spinal cord interneu-
rons. As summarized in Table 3, different episodic neurological
signs can occur in dogs and should be separated from paroxysmal
dyskinesias.
In quadrupedal animals, dystonic signs are in part different to
those in human patients. On four limbs, the animals have a better
ability to compensate for moderate motor dysfunctions (11). Dys-
tonic movements can present as gait abnormalities and dystonic
postures of the body may result in a hunched or bent back. Severe
ataxia, accompanied bymuscleweakness, can lead to axial twisting
movementswhich are not dystonic (34). The occurrence ofmuscle
weakness always argues against the diagnosis of dystonia (35).
ETIOLOGY AND PATHOPHYSIOLOGY
Dystonia was formerly divided into “primary (idiopathic) dysto-
nia” and “secondary (symptomatic) dystonia.” Primary dystonia
(as well as primary paroxysmal dyskinesias) was determined by
the lack of a defined disease and the absence of neuropathological
alterations, visible by brain imaging (MRI and CT) or by post-
mortem histological standard techniques (13). However, these
examinations do not exclude changes in the density of specific
types of neurons and microstructural alterations (11). Further-
more, there is a scarcity of human postmortal tissue donation suit-
able for more specific microscopic, neurochemical and molecular
analyses (36).
With regard to new insights into the etiology of inherited
dystonia, the division of primary versus secondary is no longer
Frontiers in Veterinary Science | www.frontiersin.org November 2015 | Volume 2 | Article 653
R
ichteretal.
D
yskinesias
in
D
om
estic
A
nim
als
TABLE 3 | Clinical characteristics of episodic disorders in animals.
Discriminator Paroxysmal
dyskinesia
Idiopathic
head tremor
Epileptic seizure Vestibular attack Syncope Narcolepsy/
Cataplexy
Neuromuscular
weakness
Paroxysmal behavior
changes
(compulsive disorder)
Clinical
status
between
episodes
Unremarkable Unremarkable Unremarkable or
forebrain signs
Unremarkable Normal heart rate
or arrhythmia, pulse
deficits, heart
murmur, cyanosis,
abnormal lung
auscultation
Altered
sleep/wake
cycle, normal
clinical
examination
Unremarkable or
generalized
weakness, muscle
atrophy, pain, and
decreased reflexes
Unremarkable
Precipitating
event or
trigger
None or activity,
exercise, excitement,
and stress
None or stress,
fatigue, and
overstimulation
None or flashing lights,
anxiety, and stress
None Exercise,
excitement, and
stress
Excitement and
eating
Activity and
exercise
Behavioral triggers (e.g., fear)
Pre-event
changes
Not applicable Not applicable Preictal signs may be
observed including
anxiety, restlessness,
increased affection,
contact-seeking,
withdrawal, hiding,
aggressiveness, and
vocalization
Not applicable Not applicable Not applicable Not applicable Not applicable
Event
description
Dystonia, chorea,
ballismus, athetosis,
tremors, impaired
posture, and inability
to stand or walk
Vertical or
horizontal
rhythmic head
movement
(5–8Hz)
Depending on seizure
focus, focal or
generalized, tonic–clonic
movements most
common
Cardinal signs of
vestibular dysfunction
present: head tilt,
nystagmus, vestibular
ataxia, and collapse
toward side of head tilt
Brief, sudden
collapse, and rapid
recovery
Sudden
collapse
Stiff, stilted gait
prior to collapse
Pacing, barking, licking,
chasing imaginary objects or
tail, and chewing objects
Level of con-
sciousness
Unremarkable Unremarkable Often impaired or
unconscious
Unremarkable or
disorientated
Reduced to absent Unremarkable if
only cataplexy.
Absent (asleep)
in narcolepsy
Unremarkable Unremarkable
Autonomic
signs
Not applicable Not applicable Possible: hypersalivation,
defaecation, and
urination
Not applicable Possible
abnormalities of
heart rate and
rhythm
Not applicable Not applicable Not applicable
Muscle tone Hypertonicity (focal
or generalized)
Normal Typically increased: tonic
(hypertonicity) or
alternating tonic–clonic
movements
Unilateral decrease in
extensor muscle tone
Flaccid (all body) Flaccid (all body) Often flaccid (can
appear spastic with
certain myopathies)
Normal
Lateralizing
signs
Possible Not applicable Possible Yes Not applicable Not applicable Not applicable Not applicable
Duration Seconds to hours Seconds to
hours
Seconds to minutes or
>5min in case of status
epilepticus
Seconds to hours Seconds Seconds to
minutes
Minutes to hours Minutes to hours
(Continued)
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recommended (1). As extensively reviewed, gene mutations
related to human dystonia currently designated as DYT1-25 (see
Table 4) were isolated and for more than half of these genes
encoded proteins were identified. The functions of these proteins
include dopamine signaling, ion channels, protein chaperoning,
transcriptional regulation, or transporters (37–40). A causative
factor has been identified in around one-third of cases of human
dystonia (1). As known for DYT1 (the most common inherited
human dystonia), a gene defect does not always lead to a dystonic
phenotype, i.e., the penetrance can be incomplete (2). Further-
more, a specific mutation can lead to various clinical pheno-
types, indicating the importance of environmental or additional
genetic factors in the pathophysiology. Alterations in neuronal
plasticity, i.e., the ability of the nervous system tomorphologically
and/or biochemically change neural pathways and synapses in
response to environmental factors, have been hypothesized to play
an important role in dystonic signs (41–43). Thereby, various
observations in humans and animal models can be explained
(11), such as the overt neuronal dysfunction without apparent
neuropathology and the often progressive nature.
Despite the varied etiology and often sporadic occurrence (no
evidence for inheritance), there are probably commonpathways in
the pathophysiology of dystonia, though this is still poorly under-
stood. There is strong evidence that dysfunction of the basal-
ganglia nuclei and related thalamocortical network are essential
(44, 45). Thus, symptomatic (acquired) dystonia is often related
to brain lesions in the basal-ganglia and thalamic nuclei. Abnor-
mal neuronal activity in the striatum, the input structure of the
basal ganglia, can lead to disturbed inhibition of thalamocor-
tical projections (11, 13, 46). Over time this may lead to an
increase in striatal, cortical, and brain stem plasticity producing
neural reorganization and symptoms of dystonia (4). This con-
cept is in line with the observed improvement of dystonia after
deep brain stimulations (DBS) of the globus pallidus internus
(GPi), a basal-ganglia output structure. Although regarded as a
basal-ganglia disorder, other brain regions can be involved in
dystonic symptoms, such as the thalamus, cortex, brain stem,
and the cerebellum (44, 47). Indeed, thalamocortical activities
are controlled not only by the basal ganglia but also by the
cerebellum. Cerebellar dysfunctions can be included [as indi-
cated by clinical data and findings in animal models (10, 48–
51)], although the most commonly recognized cerebellar signs
ataxia, vestibular dysfunction, and ocular nystagmus are usually
not present in dystonia. Functional neuroimaging data suggest
that dystonia is a neurocircuit disorder, involving the cortico-
striato-pallido-thalamo-cortical and cerebello-thalamo-cortical
pathways (44).
Inherited, idiopathic types have been suggested to be related
to neurochemical imbalances, including dopamine, acetylcholine,
and GABAergic disinhibition (44, 46). Several lines of evidence
indicated that striatal dopaminergic dysfunctions play an impor-
tant role in the pathogenesis of dystonia (52, 53). Not all neuro-
transmitter systems have been well examined yet (e.g., serotonin
and glutamate).
In summary, the etiology and pathophysiology of dystonic
signs is heterogeneous. A very important research objective is the
identification of common functional pathways to detect targets
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TABLE 4 | Etiology of inherited dystonia in humans (38, 39, 37).
Designation Clinical type Clinical characteristics Mode of inheritance Gene locus Gene
DYT1 Isolated dystonia Early-onset generalized Autosomal dominant 9q TOR1A
DYT2 Isolated dystonia Early-onset generalized Autosomal recessive Unknown Unknown
DYT3 Combined, persistent dystonia X-linked dystonia-parkinsonism; “lubag” X-chromosomal recessive Xq TAF1
DYT4 Isolated dystonia Whispering dysphonia Autosomal dominant 19p TUBB4
DYT5 Combined, persistent dystonia Dopa-responsive dystonia; Segawa syndrome Autosomal dominant 14q GCH1
DYT6 Isolated dystonia Adolescent-onset mixed phenotype Autosomal dominant 8p THAP1
DYT7 Isolated dystonia Adult-onset focal Autosomal dominant 18p Unknown
DYT8 Combined, paroxysmal dystonia Paroxysmal non-kinesigenic dyskinesia 1 Autosomal dominant 2q MR-1
DYT10 Combined, paroxysmal dystonia Paroxysmal kinesigenic dyskinesia 1 Autosomal dominant 16p-q PRRT2
DYT11 Combined, persistent dystonia Myoclonus-dystonia Autosomal dominant 7q SGCE
DYT12 Combined, persistent dystonia Rapid-onset dystonia-parkinsonism Autosomal dominant 19q ATP1A3
DYT13 Isolated dystonia Adolescent-onset multifocal/segmental Autosomal dominant 1p Unknown
DYT15 Combined, persistent dystonia Myoclonus-dystonia Autosomal dominant 18p Unknown
DYT16 Combined, persistent dystonia Early-onset generalized with parkinsonism Autosomal recessive 2p PRKRA
DYT17 Isolated dystonia Adolescent-onset Autosomal recessive 20pq Unknown
DYT18 Combined, paroxysmal dystonia Paroxysmal exertion-induced dyskinesia Autosomal dominant 1p SLC2A1 (GLUT1)
DYT19 Combined, paroxysmal dystonia Paroxysmal kinesigenic dyskinesia 2 Autosomal dominant 16q Unknown
DYT20 Combined, paroxysmal dystonia Paroxysmal non-kinesigenic dyskinesia 2 Autosomal dominant 2q Unknown
DYT21 Isolated dystonia Adult-onset generalized/multifocal Autosomal dominant 2q Unknown
DYT23 Isolated dystonia Adult-onset cervical dystonia Autosomal dominant 9q CIZ1
DYT24 Isolated dystonia Adult-onset craniocervical dystonia Autosomal dominant 11p ANO3
DYT25 Isolated dystonia Adult-onset cervical dystonia Autosomal dominant 18p GNAL
for therapeutics which are effective for a broader spectrum of
different types of dystonia.
TREATMENT
Except in some cases of acquired dystonia and inherited dopa-
responsive dystonia in humans, causal or pathogenesis-targeted
therapy is not available (54). Aims are to reduce or abolish invol-
untarymovements and postures, relieve pain, and improve quality
of life in human patients (55).
A licensed drug for symptomatic treatment of focal dystonias
in humans is botulinum toxin (BoNT). It is the treatment of
choice for focal dystonia, such as blepharospasm and cervical
dystonia. After injections into dystonic muscles, the toxin blocks
the release of acetylcholine for 2–4months and thereby improves
symptoms. Besides the modulation of motor output by blocking
cholinergic synapses, it has been hypothesized thatmore sustained
improvement results frommodulating the central plasticity via the
afferent system (56).
Empirical trials in humanpatients have shown that the response
to systemicmedication depends on the type of dystonia and shows
individual diversity, as described by Jankovic (54, 55). Treatment
with low doses of levodopa (precursor of dopamine) is very
effective in patients with generalized dopa-responsive dystonia,
which is caused by deficient dopamine synthesis. On the contrary,
dopamine blocking or depleting agents, such as neuroleptics and
tetrabenazine, sometimes improve other forms of dystonia. As
known from trials with anticholinergic drugs, treatment over
weeks with high doses is often needed before the severity of
dystonic symptoms is reduced. Drugs which enhance GABAergic
inhibition, such as baclofen (GABAB receptor agonist) and ben-
zodiazepines (diazepam and clonazepam) can also be effective.
Specific types of paroxysmal dyskinesia improve by antiepileptic
treatment (see Table 2).
Pharmacological treatment of generalized dystonia in humans
is often ineffective. Myo- and neurotomy have been replaced by
DBS, with the GPi as the target of choice (57, 58). Interestingly,
patients often show a gradual and slow course of improvement,
suggesting a role for secondary plastic changes in response to the
changed basal-ganglia output from DBS (13).
DYSTONIA IN LAB ANIMAL MODELS
During past decades, several animal models of dystonia have
been proposed with the aim to give insights into its pathophys-
iology and to develop new therapeutics. It is well described that
dystonic signs can be induced in animals or can be caused by
spontaneous mutations in rodents. Based on the identification
of gene defects in human dystonia/paroxysmal dyskinesia, mice
and rats have been genetically modified and exhibit moderate
motor disturbances. For detailed descriptions of animal models of
dystonia, see previous reviews on this topic (9–12). Here, we wish
to emphasize that spontaneous mutations leading to persistent
generalized dystonic symptoms cause a low viability in affected
rodents. Notably, detailed examinations (phenotyping) are impor-
tant to decide if motor disturbances in laboratory animals actually
represent dystonia. For example, dystonic episodes in dtsz mutant
hamsters were initially misinterpreted as reflex epilepsy, although
there is neither loss of consciousness nor EEG changes, autonomic
signs or a response to antiepileptic drugs. Indeed, the signs in
mutant hamsters show the characteristics of human paroxysmal
non-kinesigenic dyskinesia with dystonia as the dominant fea-
ture and are based on basal-ganglia dysfunctions (59). Another
example is the Cacna1a mutant tottering mouse which shows a
persistentmild ataxia and brief epileptic seizures, but also episodic
dyskinesia with coactivation of antagonisticmuscles which are not
accompanied by EEG changes. Dyskinesia in these mice is related
to cerebellar dysfunction (5–10). In experimental animal models,
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EEG recordings can be done invasively via chronically implanted
electrodes. In contrast, exclusion of spike-waves abnormalities
by non-invasive EEG recordings in domestic animals during
episodes is usually not possible because of muscle activity causing
artifacts. This should be kept in mind regarding the descriptions
of paroxysmal dyskinesias in dogs (see below).
HYPERKINETIC MOVEMENT DISORDERS
IN DOMESTIC ANIMALS: COMMON
FEATURES WITH TYPES OF HUMAN
DYSTONIA AND DYSTONIA-ASSOCIATED
DYSKINESIAS
The unspecific term “hyperkinesia” refers to different involun-
tary movements with increased motor activity. Several veterinary
reports use this term to describe animals presenting dystonic-
like features and paroxysmal dyskinesias. Most of these reports
describe paroxysmal movement disorders (Table 5), difficult to
differentiate from other episodic events, such as epileptic seizures
(60). This does not mean that persistent types of dystonia do not
occur in domestic animals; they may perhaps be under-reported
in the literature if the degree of disability caused by the persistent
generalized dystonia and/or an unsuccessful treatment lead to
the decision to euthanize the affected animal. Severe types of
dystonic postures can be painful in human patients (55), while
this is unknown in affected animals. On the other hand, theremay
be mild forms or benign courses of dystonia in animals that do
not require treatment (61) and/or are possibly not presented to a
veterinarian.
Descriptions of cases and postmortem brain examinations of
euthanized animals could give interesting insights into the patho-
physiology. The domestic dog offers unique advantages to identify
gene defects and mechanisms of inherited diseases because of the
sequenced canine genome and the closed population structures in
the breeds. Therefore, canine models may provide a valuable tool
for discovering disease alleles that have been difficult to find by
studying human families or populations (61, 62).
Motor Disturbances Which Possibly Share
Common Features with Focal Dystonias
Focal dystonias involve a single body region, and may include
involuntary rotation of the head/neck (cervical dystonia), dystonic
muscle activation of the orbicularis oculi (blepharospasm), larynx
(spasmodic dysphonia), or limb muscles (63). The initial symp-
toms can be mild and may be noticeable only after prolonged
exertion or stress. The etiology is heterogeneous and multiple
factors (e.g., overuse of muscles and central/peripheral insults)
can be involved in their manifestation, probably related to loss of
inhibition and disturbed sensorimotor integration (32, 64).
Focal dystonia can be experimentally induced in animals (65)
and cases of focal muscle contractions in domestic animals may
resemble human focal dystonia. Meyer-Lindenberg et al. (66)
described an interesting case of severe bilateral blepharospasm
in a Great Dane dog. Following a moderate bilateral ectropium,
blepharospasm (which was intensified by stress and bright light)
could be observed from an age of 8months. The spasms worsened
and resulted in a permanent closure of the eyelids. Topical anes-
thetic and systemic treatments, including tetrazepam, were not
effective. EMG revealed complex high frequency discharges of the
orbicularis oculimuscle. Finally, subcutaneous injections of BoNT
in the area of the orbicularis oculi muscle resulted in disappear-
ance of blepharospasm for 3–4months (66). As observed in this
dog, eye disorders commonly also precede human blepharospasm
which is responsive to BoNT (63).
Bovine spastic paresis (BoSP) is a progressive neuromuscular
diseasewhich has been investigated for several decades, as recently
reviewed by De Vlamynck et al. (67). BoSP occurs sporadically
in most breeds of cattle with an estimated prevalence of 0.1–0.8.
BoSP is currently considered to be inherited via autosomal reces-
sive (not identified) gene(s) with incomplete penetrance. As in
DYT1 dystonia in humans (13), it has been suggested that addi-
tional unidentified factors are important for the development of
clinical signs in genetically predisposed calves (67). There are
several obvious similarities to human limb dystonia. BoSP is
commonly associated with repetitive contractions of the gastroc-
nemius muscles but also of other hindlimb muscles. Attempts to
move are thought to aggravate cocontractions of extensors and
flexors of the limb. The age of onset ranges from 1 day to 3 years.
Starting with moderate symptoms, the clinical signs worsen over
time and result in disabling unilateral or bilateral hyperextension
of the hindlimb(s). EMG studies have demonstrated significantly
increased activity of the gastrocnemius and superficial digital
flexormuscles in standing animals. There is nomedical treatment.
Surgical procedures usually performed in affected calves include
partial tibial neurectomy, but contractions of other muscles per-
sist. It has been hypothesized that muscle contractions are caused
by disinhibition of motor neurons. Pathomorphological changes
were not detected (67). Interestingly, a lower concentration of
homovanillic acid was found in the cerebrospinal fluid of affected
calves, indicating that dopamine metabolism is reduced in the
CNS (68). Recent cDNA microarray data, performed on spinal
cords of BoSP and healthy calves of a Romagnola cattle breed
pointed to a possible alteration of calcium signaling proteins
(69). However, the etiology and pathogenesis of BoSP remain
unknown.
Generalized Movement Disorders Which
Possibly Include Dystonic Features
Paroxysmal Dyskinesias in Dogs
Episodic falling in Cavalier King Charles Spaniels (CKCS), an
autosomal-recessive inherited disorder (70, 71), shares similarities
with human paroxysmal dyskinesia (61). In affected dogs, exercise
and excitement can precipitate episodes of abnormal gait and
fallings which last up to several minutes (Video S1 in Supple-
mentary Material). There are no signs of an impairment of con-
sciousness or autonomic dysfunction during or after these attacks
(72). Affected animals develop an increased extensor muscle tone
of all four limbs, resulting in an immobilized, “deer-stalking” or
“praying” position, sometimes falling with legs held in extensor
rigidity (70, 73). Other clinical signs are facial muscle stiffness,
stumbling, a “bunny-hopping” gait, and arching of the back. It
is unclear if cocontractions of flexors are involved. Initial clinical
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TABLE 5 | Hyperkinetic disorders in domestic animals, possibly including dystonic signs.
Species Breeda Characteristics indicating the presence of dystonia Genetic defect/
pathophysiology
Denomination
in veterinary
medicine
Assumed comparable
type of
human dystonia
Dog Cavalier
King
Charles
Spaniel
Episodes of involuntary twisting movements and abnormal
postures of trunk and extremities with muscular hypertonicity,
resulting in complete immobility
Autosomal-recessive
mode of inheritance
15.7 kb deletion in the
gene BCAN (encoding
brain-specific
extracellular
matrix-proteoglycan
brevican)
Episodic
falling/
hypertonicity/
sudden
collapse
Paroxysmal
(non-)kinesiogenic
dystonia
Episodes are inducible by excitement/stress or exercise
Duration of episodes: up to minutes
Consciousness is unaltered
Treatment with benzodiazepines (clonazepam 0,5mg/kg) and
carbonic anhydrase inhibitors (acetazolamide) can be attempted
Scottish
Terrier
Episodes of involuntary movements, starting with an increase in
muscle tone and arching of the back, stiffness of extremities
resulting in loss of balance
Unknown/autosomal-
recessive mode of
inheritance
serotonergic and/or
dopaminergic
dysfunctions are
presumed
Scottie
cramp
Paroxysmal
(non-)kinesiogenic
dystonia
Episodes are inducible by stress and effort/exercise as well as by
amphetamine (induces dopaminergic overactivity)
Duration of episodes: up to minutes
Consciousness is unaltered
EMG abnormalities
Treatment with benzodiazepines (diazepam 0,5–1,5mg/kg)
Chinook
dog
Episodes of involuntary twisting movements and abnormal
postures of trunk and extremities with muscular hypertonicity,
partly with head tremor
Unknown/probably
autosomal-recessive
mode of inheritance
Chinook
seizures
Paroxysmal dyskinesia
Trigger: uncertain
Duration of episodes: up to 1 h
Consciousness is unaltered
Border
Terrier
Episodes of involuntary movements Unknown Canine
“epileptoid”
cramping
syndrome
Paroxysmal
non-kinesiogenic
dystonia
Episodes are inducible by excitement and waking from sleep
Often associated with mild tremor and gastrointestinal signs
(borborygmi, vomiting and diarrhea)
Duration of episodes: 2–30min up to three times per day
Yorkshire
Terrier
Episodes of generalized, sustained and painful involuntary muscle
contractions
Unknown/case report
no changes found by
MRI and CT
– Paroxysmal hyperkinetic
disorder
Duration of episodes up to 30min, four times per day
Consciousness is unaltered
Boxer Episodes of twisting movements and postures of trunk and
extremities with muscle hypertonicity, torticollis, and “grimacing”
Unknown/hereditary – Paroxysmal dystonia
Episodes are inducible by excitement
Duration of episodes: ~1–5min
Consciousness is unaltered
Bichon
Frisé
Episodes of abnormal twisting movements and postures of trunk
and extremities, kyphosis, and “grimacing”
Unknown/case report – Paroxysmal hyperkinetic
disorder
Episodes occur spontaneously also at rest or are inducible by
excitement/stress/effort
Consciousness is unaltered
German
short-
haired
pointer
Episodes of abnormal twisting movements and postures of trunk
and extremities
Unknown/case report – Paroxysmal hyperkinetic
disorder
Episodes are inducible by stress/excitement/effort
Duration of episodes: 10min to 3 h
Consciousness is unaltered
Successful treatment with phenobarbital (30mg/kg)
Dalmatian
dog
Hyperkinetic episodes with rigidity/hyperextension/twisting
movements and postures of extremities as well as head and neck
(torticollis), rigidity of paraspinal muscles, resulting in scoliosis and
loss of balance/falling and immobility
Unknown/case report – Paroxysmal hyperkinetic
disorder
Episodes are inducible by excitement/stress and exercise
Duration of episodes: ~15–60min
Consciousness is unaltered
Successful treatment with azetazolamide (0,1mg/kg)
Great
Dane
Bilateral blepharospasm Unknown/case report – Focal dystonia
(blepharospasm)Successful therapy with local application of botulinum toxin A
(Continued)
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TABLE 5 | Continued
Species Breeda Characteristics indicating the presence of dystonia Genetic defect/
pathophysiology
Denomination
in veterinary
medicine
Assumed comparable
type of
human dystonia
Horse Various
breeds
Episodic occurrence of involuntary muscle contractions, mostly in
the pelvic region and the hind limbs
Episodes are inducible by exercise, stress and excitement
Duration of episodes: seconds to minutes
Unknown/hereditary?
End-terminal
neuroaxonal lesion in
the deep cerebellar
nuclei
Shivering Paroxysmal dystonia?
Episodes of involuntary muscle contractions in the rear body parts
but also in the nasolabial region
Unknown/ Stiff-horse
syndrome
Paroxysmal dyskinesia?
Episodes are inducible by exercise and excitement
Cattle Various
breeds
Progressive consistent contractions of the hindlimb muscles Unknown possibly
autosomal recessive
(reduced penetrance?)
Bovine
spastic
paresis
Limb dystonia
Belgian
Blue,
Chianina,
Dutch
Improved
Red and
White
Stress/effort and external stimuli provoke enhanced muscle tone,
resulting in hyperflexion of all extremities and disability to stand or
walk
Mutation in the gene
ATP2A1 (encoding for
a Ca2+-ATPase
[SERCA1] leads to
disturbances in the
Ca2+-reuptake from
the cytosol in the
endoplasmic reticulum)
Congenital
muscular
dystonia type
1 (CMD1)
Brody myopathy? (not
dystonia)
Belgian
Blue
Acoustic or tactile stimuli are leading to episodes of sustained
muscle contractions with twisting, repetitive movements and
postures
Microdeletion in the
gene Glyt2 (SLC6A5)
(encoding for a
presynaptic transporter
of glycine)
Congenital
muscular
dystonia type
2 (CMD2)
Hyperekplexia/startle
disease? (not dystonia)
aFor references, see text section.
signs of the disease typically appear between 3 and 7months of
age. Interestingly, in some cases, there is spontaneous remission,
as sometimes observed in human paroxysmal dyskinesia (74).
There is no evidence for metabolic alterations as a cause, and
light microscopic examinations have not revealed any lesions in
the CNS or peripheral nerves (75). Clonazepam may be effec-
tive in suppressing the episodes in some cases (76). Recently, a
15.7 kb deletion in BCAN, encoding the brain-specific extracellu-
lar matrix-proteoglycan brevican, was found to be associated with
episodic falling in CKCS (61, 77). This protein plays an important
role in cell adhesion, migration, axon guidance, and neuronal
plasticity (78).How thismutation leads to themanifestation of this
hyperkinetic movement disorder in dogs has yet to be unraveled.
Scottie cramp is a paroxysmal hyperkinetic disorder in Scottish
terriers (Video S2 in Supplementary Material), with onset usually
occurring during the first year of life. This autosomal-recessive
inherited disorder shows features of paroxysmal dyskinesia (72,
79–83). Affected dogs appear normal at rest. When performing
lengthy exercise or excited, the dogs progressively develop a stiff,
stilted gait over a few minutes. Initially, the dogs show an arching
of the lumbar region of the back, progressing with a stiff-legged
gait with the pelvic limbs overflexed and thoracic limbs abducted
with increased extensor tone while walking. Occasionally, exag-
gerated flexion of the limbs against the body can be observed. The
gait abnormalities progress until some dogs are unable to walk
or fall into recumbency with a flexed neck and tail. Furthermore,
clear abnormalities could be observed by EMG analyses during
an episode, including higher amplitudes and longer duration of
the interference pattern in affected muscles (84). There is a wide
variety of clinical signs. While some Scottish terriers seem to
rather exhibit myoclonic jerks, other dogs show a phenotype that
clearly resemble dystonic movements [for video, see also Ref.
(83)]. The affected dogs are fully conscious during the whole
attacks, which usually last a few minutes. Affected dogs recover
completely after a period of rest. Nomicroscopically visible lesions
have been found in the nervous system. The attacks of involuntary
movements can be provoked by administration of amphetamine
and can be suppressed with diazepam or acepromazine. In con-
trast, antiserotonin agents markedly increased the severity. While
serotonin reuptake inhibitors can provoke acute dystonic symp-
toms in humans (85), fluoxetine and other drugs which enhance
cerebral serotonin concentrations have been reported to reduce
the severity of Scottie cramp (86). Therefore, it has been suggested
that the syndrome may be related to a deficiency of serotonin,
although quantification of brain serotonin content did not reveal
differences from healthy dogs (87, 88). Severe forms of Scottie
cramps are refractory to fluoxetine and show a better response to
diazepam (83).
Hereditary idiopathic paroxysmal dyskinesia in Chinook dogs
probably has an autosomal-recessive inheritance (89). The dogs
exhibit episodes of dyskinesia with dystonia [e.g., torsions of
limb(s)], chorea, and ballismus, and in some cases also head
tremors. The attacks last from minutes to 1 h and can occur
several times per day or less frequently (up to years between
attacks). These episodes are not induced by sudden movements,
and other triggers have not been described in Chinook dogs. Age
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of onset ranges from 2months to 5 years, but usually the first
attack appears during the first 3 years of life. The attacks are not
associated with autonomic signs or loss of consciousness. EEG
recordings demonstrated that the episodes usually occur in the
absence of epileptic activity, but three dogs of one family exhib-
ited generalized tonic–clonic epileptic seizures in addition to the
clinical signs of paroxysmal dyskinesia. Indeed, it is known from
human individuals that specific mutations can lead to a paroxys-
mal dyskinesia that is associated with epilepsy in some affected
family members (90, 91). Therefore, Packer et al. (89) suggested
that paroxysmal dyskinesia in Chinook dogs could result from
a channelopathy, but further analyses are required to confirm
this. Public videos show sequences of paroxysmal dyskinesia in
Chinook dogs. The thorough description by Packer et al. (89)
indicates that the movement disorder in the Chinook dogs shares
common features with paroxysmal non-kinesigenic dyskinesia in
human individuals.
The canine “epileptoid” cramping syndrome in the Border terrier
(Video S3 in Supplementary Material) has been hypothesized to
represent a form of paroxysmal non-kinesigenic dyskinesia (92).
As indicated by a retrospective owner-directed study, the first
episodes usually occur before 3 years of age. Although the episodes
often appear spontaneously, owners identified excitement and
waking from sleep as inducing factors. Themajority of generalized
attacks lasted 2–30min, occurred up to three times per day and
were often associated withmild tremor and borborygmi. Immedi-
ately before or after the episodes, gastrointestinal signs (vomiting
and diarrhea) were observed in about 50% of the affected dogs,
which has not been reported in human dystonia or paroxysmal
dyskinesia. While antiepileptic drugs were ineffective, the move-
ment disorder is responsive to a gluten-free diet. A recent study
demonstrated a link of the condition to gluten sensitivity. Affected
border terriers had increased serum titers of antitransglutaminase
2 and antigliadin antibodies which normalized when the dogs
were fed a gluten-free diet (93).
A movement disorder in boxer pups shows similarities with
features of human paroxysmal non-kinesigenic dyskinesia (94).
Two unrelated litters of six (all affected) and nine (seven affected)
pups developed “unusual neurological episodes,” triggered by
excitement and lasting for 1–5min, at 8 weeks of age. The fre-
quency ranged from only two episodes in 6months to 10 episodes
per day. Interestingly, the frequency and duration of episodes
decreased with age and were less frequent and less severe in
females compared with males. Clinical signs included unilateral
facial dystonia, producing grimacing, lifting of an extended tho-
racic limb which was either held elevated for several seconds
or banged to the ground, unilateral dystonia of the neck and
truncal muscles producing torticollis, and hyperflexion of a tho-
racic or pelvic limb. The pups were at all times conscious. MRI
scans of the brain of an affected male pup did not show obvious
abnormalities.
Case Reports of Episodic Movement Disorders in Dogs
As summarized in Table 5, there are further case reports of
episodic hyperkinetic disorders in a Bichon frise (95), a German
shorthaired pointer (96), and two Dalmatian dogs (97). Park
et al. (98) described a paroxysmal movement disorder in a young
Yorkshire terrier. The attacks of generalized, sustained muscle
contractions, lasting about 30min with a frequency of 4 per day,
were accompanied neither by loss of consciousness nor by any
alterations in the CNS, as determined by MRI and CT. Similar
episodic movement disorders have been described in Springer
Spaniel dogs, Norwich terrier, Soft Coated Wheaten terrier, and
Maltese dogs (99–101), indicating that spontaneous or inherited
paroxysmal dyskinesias occur in several dog breeds.
Generalized Clinical Signs in Horses
Shiveringrepresents a neuromuscular syndrome in horses, rec-
ognized as early as 1910 (102). The horses exhibit episodes of
involuntary muscle contractions with trembling of the pelvic
limbs (shivering), sudden jerky extensor movements of the tail
and raising of one hindlimb in a semiflexed, abducted position for
a few seconds to minutes (103, 104). The horses show otherwise
normal behavior. Shivering can occur at any age, and the severity
may remain unchanged or may slowly progress (72). In more
severe cases, involvement of the muscles of the forelimbs, the
neck, the trunk, and the face is described (103). The involuntary
movements are worsened by stress or excitement and can be
abolished by rest. The cause of shivering is still unknown, and
an effective treatment is not available. It has been suggested that
shivering has a hereditary background and may involve neuro-
chemical alterations in the basal-ganglia nuclei (103). However,
recent immunohistochemical and ultrastructural investigations
indicated that shivering is related to end-terminal neuroaxonal
degeneration in the deep cerebellar nuclei (105). In view of some
common symptoms, this neuromuscular syndrome in the horse
may include dystonic features. Specific studies, such as EMG
recordings, are necessary.
The stiff-horse syndrome is characterized by episodes of con-
tractions in the muscles of the lower back and of the hindlimbs.
Facial contractions may occur in some cases (106, 107). Usually,
the episodes of muscle contractions, which last a few minutes,
can be precipitated by stress but also by voluntary movements.
EMG analysis showed persistent motor-unit activity over a few
minutes in the axial and gluteal muscles (107). The stiff-horse
syndrome has been presumed to be caused by a loss of GABAergic
inhibition within the CNS (103). However, the cause is unknown,
and it is unclear if this movement disorder in horses repre-
sents a type of paroxysmal dyskinesia or if it shares common
features with the stiff-person-syndrome, characterized by pro-
gressive rigidity and muscle spasms affecting the axial and limb
muscles (108).
Although this review focuses on hereditary dystonia/
paroxysmal dyskinesias, we here refer to an interesting type of
secondary dyskinesia with dystonic signs in horses. Chronic
ingestions of yellow star thistle (Centaurea solstitialis) or
Russian knapweed (Centaurea repens) can cause nigropallidal
encephalomalacia in horses with an abrupt onset of neurologic
signs, including the occurrence of dystonic symptoms in facial,
lip, and tongue muscles as well as gait abnormalities (109). There
is no loss of dopaminergic neurons, but lesions occur in the
globus pallidus and in the substantia nigra pars reticularis (110),
supporting the hypothesis that abnormal basal-ganglia output
plays an important role in the pathophysiology.
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Generalized Clinical Signs in Cattle
The so-called congenitalmuscular dystonia (CMD) type 1 and type
2 are reported to have an incidence of 0.1–0.2% in Belgian Blue
cattle (111–113). All calves with CMD exhibit episodes of gener-
alized muscles contractions with two distinct phenotypes. Calves
with CMD1 show impaired swallowing, fatigue upon stimulation,
and myotonia resulting in a complete stiffness of limbs. Usually,
respiratory complications lead to death a few weeks after birth.
CMD2 is characterized by severe episodes of myoclonus after
acoustic or tactile stimuli (clinically resembling the disinhibited
human startle reaction) with death of calves within a few hours
after birth. These clinical signs obviously differ from human dys-
tonic conditions. In fact, genetic analyses have revealed a muscle
defect. CMD1 is associated with a mutation in the gene ATP2A1,
encoding the fast-twitch skeletal muscle Ca2+-ATPase (SERCA1)
that results in disturbed Ca2+ reuptake into the sarcoplasmatic
reticulum at the end of the contractile phase (111). Therefore,
CMD1 shows common mechanisms with Brody myopathy in
humans (111) rather than with dystonia. Exercise-inducedmuscle
contractions, termed as “pseudomyotonia” in Chianina cattle and
in a Dutch cross-breed, are associated with SERCA1 gene (114–
116). Furthermore, genetic analyses have shown that CMD2 is
caused by a GlyT2 (SLC6A5) defect, comparable to the findings in
human hyperekplexia and Irish Wolfhounds with hyperekplexia
(111, 112, 117). Therefore, these movement disorders in cattle do
not seem to be a type of dystonia and therefore should be renamed.
CONCLUSION
Involuntary hyperkineticmovement disorders that share common
clinical features with different types of dystonia and paroxysmal
dyskinesias in humans are described in dogs, horses, and cat-
tle. While genetic analyses have shown that the currently rec-
ognized movement disabilities termed as CMD in cattle do not
seem to represent dystonia, it has yet to be clarified if hyper-
kinetic movements in dogs and horses are dystonic in nature.
As neurophysiological examinations in patients with dystonia
show specific EMG patterns, this may help to clarify diagnosis.
Since muscle cocontractions of antagonistic muscles and phasic
tremulous and/or non-tremulous muscle activity represent the
hallmarks of dystonia, these would help to distinguish between
possible diagnoses in affected animals. Although attempts at treat-
ment with GABAmimetic drugs like benzodiazepines in dogsmay
be effective in some cases, the outcomes are inconsistent. Except
for disorders with clearly defined genetic causes, the origin and
the mechanisms underlying of the described movement disor-
ders in domestic animals remain mostly unknown. Therefore,
further postmortem studies and genetic analysis to determine the
underlying pathophysiology and genetics of these conditions are
required.
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